Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Lowy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|June 10, 2016
Cancer moonshot countdownDouglas Lowy, Dinah Singer, Ron DePinho, et al.
Medrxiv : the Preprint Server for Health Sciences|March 2, 2022
Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World DataShannon L Reynolds, Harvey W Kaufman, William A Meyer, et al.
Plos One|March 21, 2023
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world dataShannon L Reynolds, Harvey W Kaufman, William A Meyer, et al.
Frontiers in Oncology|January 24, 2014
Comparison of antibody responses to human papillomavirus vaccination as measured by three assaysHilary A Robbins, Troy J Kemp, Carolina Porras, et al.
Vaccine|July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaRolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
BMC Infectious Diseases|March 5, 2014
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusHilary A Robbins, Yan Li, Carolina Porras, et al.
Vaccine|March 23, 2015
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa RicaPaula Gonzalez, Allan Hildesheim, Rolando Herrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2021
Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020Keri N Althoff, David J Schlueter, Hoda Anton-Culver, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|June 10, 2016
Cancer moonshot countdownDouglas Lowy, Dinah Singer, Ron DePinho, et al.
Medrxiv : the Preprint Server for Health Sciences|March 2, 2022
Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World DataShannon L Reynolds, Harvey W Kaufman, William A Meyer, et al.
Plos One|March 21, 2023
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world dataShannon L Reynolds, Harvey W Kaufman, William A Meyer, et al.
Frontiers in Oncology|January 24, 2014
Comparison of antibody responses to human papillomavirus vaccination as measured by three assaysHilary A Robbins, Troy J Kemp, Carolina Porras, et al.
Vaccine|July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaRolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
BMC Infectious Diseases|March 5, 2014
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusHilary A Robbins, Yan Li, Carolina Porras, et al.
Vaccine|March 23, 2015
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa RicaPaula Gonzalez, Allan Hildesheim, Rolando Herrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2021
Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020Keri N Althoff, David J Schlueter, Hoda Anton-Culver, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Journal of the National Cancer Institute|August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adultsJoseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Pageof 2